Life ScienceCompany
Gilead Sciences M&A Summary
Gilead Sciences has acquired 24 companies, including 8 in the last 5 years. A total of 2 acquisitions came from private equity firms. It has also divested 3 assets.
Gilead Sciences’ largest acquisition to date was in 2020, when it acquired Immunomedics for $21.0B. It’s largest disclosed sale occurred in 2001, when it sold Gilead Oncology Business to OSI Pharmaceuticals for $200M. Gilead Sciences has acquired in 7 different US states, and 6 countries. The Company’s most targeted sectors include life science (96%) and chemicals (5%).
Gilead Sciences Business Overview
Where is Gilead Sciences headquartered?
Gilead Sciences is headquartered in Foster City, California.
What is Gilead Sciences’ revenue?
Gilead Sciences disclosed revenue of 27,116M USD for 2023 and 27,281M USD for 2022.
How many employees does Gilead Sciences have?
Gilead Sciences has 18,000 employees.
What sector is Gilead Sciences in?
Gilead Sciences is a life science company.
When was Gilead Sciences founded?
Gilead Sciences was founded in 1987.
M&A Summary
-
M&A Total Activity27
- M&A Buy Activity24
- M&A Sell Activity3
- Total Sectors Invested 2
- Total Countries Invested 6
- M&A Buy/Sell Connections 7
- M&A Advisors 17